Gooch and Housego acquires British manufacturer VITL for £22m
Gooch and Housego said it had bought UK-based medical manufacturer VITL for up to £22m as part of its efforts to expand the group's presence in the life sciences sector.
Electronic & Electrical Equipment
9,721.29
16:59 26/04/24
FTSE AIM 100
3,637.40
17:14 26/04/24
FTSE AIM 50
3,960.47
17:14 26/04/24
FTSE AIM All-Share
755.28
17:14 26/04/24
Gooch & Housego
550.00p
16:49 26/04/24
G&H's acquisition of VITL will enable the group to "take a significant step" towards meeting its strategic objectives of doubling revenue flowing into its life science business and accelerating the company's move up the value chain
The AIM-listed firm said VITL's core group of electronic, software and mechanical engineers would also provide it with an "enhanced platform" on which it can expand its own systems capabilities.
G&H will pay an initial £14m from existing resources, and issue £1.4m worth of new shares in the firm, with a deferred contingent cash consideration of up to £8m set to follow, based upon the performance of the business over the next two years.
"This acquisition provides a key step towards achieving our strategic aims of establishing 'critical mass' in our life sciences business and moving up the value chain, through a more systems-based product portfolio," said G&H chief executive Mark Webster.
"It means we are able to continue to diversify our business, allow G&H access to new high growth markets, as well as reducing, still further, dependency on the historically cyclical micro-electronic sector," he added.
G&H shares were up 1.49% to 1,522.28p.